HyperlipidaemiaNCT07740473
Therapeutic Effects of Cinnamon-Enriched Cookies on Hypercholesterolemia and Liver Function
A study testing Treatment group T1 in people with Hyperlipidaemia and Liver Biomarkers, run by University of Lahore at 1 site in Pakistan.
Trial summary
Cinnamon-enriched cookies were developed and evaluated for their sensory acceptability and potential as a functional food for adults with hyperlipidemia. The findings suggest that incorporating cinnamon into cookies alongside conventional therapy may support cardiovascular and liver health while offering a palatable… Read more about this study
- Who is it for?
- Ages 45 to 55 yearsHealthy volunteers can take part
- Conditions the study is for
- Hyperlipidaemia, Liver Biomarkers, Weight Change
- What is being tested?
- Treatment group T1
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 40 participants
- Where
- 1 sitePakistan
- Study dates
- 2 May 2024to 15 Jul 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 45 to 55 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Both men and women aged 45-55 participated in the study. The experiment targeted high-cholesterol, triglycerides, and low-density lipoprotein patients (>220, 150, and 130 mg/dL).
Who cannot join
- Individuals with diabetes, gastrointestinal issues, documented cinnamon allergies were excluded.
- -
Trial locations and contacts
1 site in 1 country.
About this study
Cinnamon-enriched cookies were developed and evaluated for their sensory acceptability and potential as a functional food for adults with hyperlipidemia. The findings suggest that incorporating cinnamon into cookies alongside conventional therapy may support cardiovascular and liver health while offering a palatable dietary intervention.
Read the detailed description
This study developed cinnamon-enriched cookies as a functional food and evaluated their sensory acceptability, physical characteristics, and potential health benefits in adults with hyperlipidemia receiving conventional therapy. The findings highlight the potential of cinnamon-enriched cookies as a convenient, acceptable, and food-based dietary strategy to support cardiovascular and liver health, encouraging the development of functional bakery products for managing hyperlipidemia.
- Conditions
- Hyperlipidaemia, Liver Biomarkers, Weight Change
- Being tested
- Treatment group T1
- Keywords
- Cinnamon, Hypercholesterolemia, Liver function, Antioxidants
- Medical subject headings
- Hyperlipidemias, Body Weight Changes, Hypercholesterolemia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Treatment group T1Dietary supplement
Conventional therapy + cinnamon-enriched cookie (1 cookie/day)
| Study group | Role | What they receive |
|---|---|---|
| T0: placebo | Placebo comparator | Conventional therapy + whole-wheat cookie once a day Receives: Dietary Supplement: Treatment group T1 |
What is being measured
The primary outcome is the main question the study is designed to answer.
Anthropometric measurement
Weight, BMI was measured
Measured: 10 weeks
Lipid Profile
Lipid Profile was observed
Measured: 10 weeks
Secondary outcomes (1)
Liver Enzymes
Liver Enzymes were observed
Measured: 10 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Jul 2026
- Study start2 May 2024
- Primary completion10 Jun 2024
- Study completion15 Jul 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HyperlipidaemiaStudies of the same condition, open and under way.
- More trials run by University of LahoreThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 40 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Lahore
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07740473
- Sponsor's protocol ID
- (REC-UOL-569/2024)
- Status last verified
- Mar 2024
- First submitted
- 28 Jul 2026
- Last updated
- 31 Jul 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 31 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Therapeutic Effects of Cinnamon-Enriched Cookies on Hypercholesterolemia and Liver Function
- ClinicalTrials.gov ID
- NCT07740473
- Acronym / sponsor ID
- (REC-UOL-569/2024)
- Conditions
- Hyperlipidaemia, Liver Biomarkers, Weight Change
- Keywords
- Cinnamon, Hypercholesterolemia, Liver function, Antioxidants
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 40 participants (actual)
- Lead sponsor
- University of LahoreUniversity, hospital or other
- Study start
- 2 May 2024 (actual)
- Primary completion
- 10 Jun 2024 (actual)
- Study completion
- 15 Jul 2024 (actual)
- First posted
- 31 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Cinnamon-enriched cookies were developed and evaluated for their sensory acceptability and potential as a functional food for adults with hyperlipidemia. The findings suggest that incorporating cinnamon into cookies alongside conventional therapy may support cardiovascular and liver health while offering a palatable dietary intervention.
Detailed description
This study developed cinnamon-enriched cookies as a functional food and evaluated their sensory acceptability, physical characteristics, and potential health benefits in adults with hyperlipidemia receiving conventional therapy. The findings highlight the potential of cinnamon-enriched cookies as a convenient, acceptable, and food-based dietary strategy to support cardiovascular and liver health, encouraging the development of functional bakery products for managing hyperlipidemia.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| T0: placebo | Placebo comparator | Dietary Supplement: Treatment group T1Conventional therapy + whole-wheat cookie once a day |
Who may qualify
- Ages
- 45 to 55 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Both men and women aged 45-55 participated in the study. The experiment targeted high-cholesterol, triglycerides, and low-density lipoprotein patients (>220, 150, and 130 mg/dL).
Key exclusion criteria (2 listed)
- Individuals with diabetes, gastrointestinal issues, documented cinnamon allergies were excluded.
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Treatment group T1Conventional therapy + cinnamon-enriched cookie (1 cookie/day) | Dietary supplement | T0: placebo |
Primary outcome
Anthropometric measurement
Time frame: 10 weeks
Weight, BMI was measured
Lipid Profile
Time frame: 10 weeks
Lipid Profile was observed
1 secondary outcome
Liver Enzymes
Time frame: 10 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Jul 2026.
- Related InfoLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Hyperlipidaemia
Not yet recruiting
Plasma Lipids-Dependent Vitamin E Metabolism During Dynamic Hyperlipidemia
Lipid Metabolism Disorders
Active, not recruiting
Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials (CONNECT)
Cardiovascular Diseases, Hypertension
Active, not recruitingPhase 3
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Primary Prevention of Atherosclerotic Cardiovascular Disease
RecruitingObservational study
Causes and Natural History of Dyslipidemias
Hypercholesterolemia, Atherosclerosis
Active, not recruitingObservational study
Early Detection of Familial Hypercholesterolaemia in Pre-school Children ( CzeCH-IT)
Familial Hypercholesterolaemia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Treatment group T1 in people with Hyperlipidaemia and Liver Biomarkers, run by University of Lahore at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 31 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Anthropometric measurement (time frame: 10 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2026.